Glenn Wilkins - Friday, May 15, 2020 ESSA Pharma Inc. 09:50 AM EST - ESSA Pharma Inc. : Today presented new preclinical data on ESSA's clinical candidate, EPI-7386, at the 2020 Virtual American Urological Association Annual Meeting. ESSA Pharma Inc. shares V.EPI are trading unchanged at $6.22.